nodes	percent_of_prediction	percent_of_DWPC	metapath
Metformin—SLC47A1—Ritonavir—acquired immunodeficiency syndrome	0.171	0.335	CbGbCtD
Metformin—SLC22A3—Lamivudine—acquired immunodeficiency syndrome	0.0662	0.13	CbGbCtD
Metformin—SLC22A1—Indinavir—acquired immunodeficiency syndrome	0.0523	0.103	CbGbCtD
Metformin—SLC22A1—Nelfinavir—acquired immunodeficiency syndrome	0.0508	0.0996	CbGbCtD
Metformin—SLC22A2—Zidovudine—acquired immunodeficiency syndrome	0.0507	0.0994	CbGbCtD
Metformin—SLC22A1—Saquinavir—acquired immunodeficiency syndrome	0.0459	0.09	CbGbCtD
Metformin—SLC22A2—Lamivudine—acquired immunodeficiency syndrome	0.0392	0.0769	CbGbCtD
Metformin—SLC22A1—Lamivudine—acquired immunodeficiency syndrome	0.0341	0.0668	CbGbCtD
Metformin—NDUFS6—Zidovudine—Stavudine—acquired immunodeficiency syndrome	0.00321	0.54	CbGdCrCtD
Metformin—NDUFA13—Zidovudine—Stavudine—acquired immunodeficiency syndrome	0.00273	0.46	CbGdCrCtD
Metformin—NDUFA5—lung—acquired immunodeficiency syndrome	0.000411	0.00187	CbGeAlD
Metformin—NDUFS4—vagina—acquired immunodeficiency syndrome	0.00041	0.00187	CbGeAlD
Metformin—NDUFS5—bone marrow—acquired immunodeficiency syndrome	0.00041	0.00187	CbGeAlD
Metformin—NDUFB8—bone marrow—acquired immunodeficiency syndrome	0.00041	0.00187	CbGeAlD
Metformin—NDUFS5—spinal cord—acquired immunodeficiency syndrome	0.000408	0.00186	CbGeAlD
Metformin—NDUFB8—spinal cord—acquired immunodeficiency syndrome	0.000408	0.00186	CbGeAlD
Metformin—NDUFAF4—lung—acquired immunodeficiency syndrome	0.000407	0.00186	CbGeAlD
Metformin—NDUFB6—lung—acquired immunodeficiency syndrome	0.000407	0.00186	CbGeAlD
Metformin—NDUFA10—nervous system—acquired immunodeficiency syndrome	0.000406	0.00185	CbGeAlD
Metformin—NDUFB4—vagina—acquired immunodeficiency syndrome	0.000405	0.00185	CbGeAlD
Metformin—NDUFS1—lung—acquired immunodeficiency syndrome	0.000404	0.00185	CbGeAlD
Metformin—NDUFAB1—vagina—acquired immunodeficiency syndrome	0.000403	0.00184	CbGeAlD
Metformin—NDUFC1—nervous system—acquired immunodeficiency syndrome	0.000402	0.00184	CbGeAlD
Metformin—NDUFB10—lung—acquired immunodeficiency syndrome	0.000402	0.00183	CbGeAlD
Metformin—NDUFB9—vagina—acquired immunodeficiency syndrome	0.0004	0.00183	CbGeAlD
Metformin—NDUFA8—vagina—acquired immunodeficiency syndrome	0.0004	0.00183	CbGeAlD
Metformin—NDUFB2—nervous system—acquired immunodeficiency syndrome	0.000399	0.00182	CbGeAlD
Metformin—NDUFA12—lung—acquired immunodeficiency syndrome	0.000399	0.00182	CbGeAlD
Metformin—NDUFB7—lung—acquired immunodeficiency syndrome	0.000399	0.00182	CbGeAlD
Metformin—NDUFA4—vagina—acquired immunodeficiency syndrome	0.000398	0.00182	CbGeAlD
Metformin—NDUFS7—blood—acquired immunodeficiency syndrome	0.000397	0.00181	CbGeAlD
Metformin—NDUFS8—lung—acquired immunodeficiency syndrome	0.000396	0.00181	CbGeAlD
Metformin—NDUFB1—lung—acquired immunodeficiency syndrome	0.000396	0.00181	CbGeAlD
Metformin—NDUFAF1—nervous system—acquired immunodeficiency syndrome	0.000396	0.00181	CbGeAlD
Metformin—NDUFV1—vagina—acquired immunodeficiency syndrome	0.000395	0.0018	CbGeAlD
Metformin—NDUFB11—vagina—acquired immunodeficiency syndrome	0.000395	0.0018	CbGeAlD
Metformin—NDUFS5—vagina—acquired immunodeficiency syndrome	0.000393	0.00179	CbGeAlD
Metformin—NDUFB8—vagina—acquired immunodeficiency syndrome	0.000393	0.00179	CbGeAlD
Metformin—NDUFA9—brain—acquired immunodeficiency syndrome	0.000392	0.00179	CbGeAlD
Metformin—NDUFA13—brain—acquired immunodeficiency syndrome	0.000392	0.00179	CbGeAlD
Metformin—ND6—nervous system—acquired immunodeficiency syndrome	0.000392	0.00179	CbGeAlD
Metformin—NDUFA10—central nervous system—acquired immunodeficiency syndrome	0.000391	0.00178	CbGeAlD
Metformin—NDUFB5—lung—acquired immunodeficiency syndrome	0.000391	0.00178	CbGeAlD
Metformin—NDUFA6—lung—acquired immunodeficiency syndrome	0.000391	0.00178	CbGeAlD
Metformin—NDUFAF2—nervous system—acquired immunodeficiency syndrome	0.000389	0.00178	CbGeAlD
Metformin—NDUFS4—lung—acquired immunodeficiency syndrome	0.000388	0.00177	CbGeAlD
Metformin—NDUFC1—central nervous system—acquired immunodeficiency syndrome	0.000387	0.00177	CbGeAlD
Metformin—NDUFA1—brain—acquired immunodeficiency syndrome	0.000386	0.00176	CbGeAlD
Metformin—NDUFS7—bone marrow—acquired immunodeficiency syndrome	0.000384	0.00175	CbGeAlD
Metformin—NDUFB2—central nervous system—acquired immunodeficiency syndrome	0.000384	0.00175	CbGeAlD
Metformin—NDUFB4—lung—acquired immunodeficiency syndrome	0.000383	0.00175	CbGeAlD
Metformin—NDUFS7—spinal cord—acquired immunodeficiency syndrome	0.000383	0.00175	CbGeAlD
Metformin—PRKAB1—digestive system—acquired immunodeficiency syndrome	0.000381	0.00174	CbGeAlD
Metformin—NDUFAF1—central nervous system—acquired immunodeficiency syndrome	0.000381	0.00174	CbGeAlD
Metformin—NDUFAB1—lung—acquired immunodeficiency syndrome	0.000381	0.00174	CbGeAlD
Metformin—NDUFA5—nervous system—acquired immunodeficiency syndrome	0.00038	0.00174	CbGeAlD
Metformin—NDUFA11—nervous system—acquired immunodeficiency syndrome	0.00038	0.00174	CbGeAlD
Metformin—NDUFB9—lung—acquired immunodeficiency syndrome	0.000378	0.00173	CbGeAlD
Metformin—NDUFA8—lung—acquired immunodeficiency syndrome	0.000378	0.00173	CbGeAlD
Metformin—ND6—central nervous system—acquired immunodeficiency syndrome	0.000378	0.00172	CbGeAlD
Metformin—NDUFAF4—nervous system—acquired immunodeficiency syndrome	0.000377	0.00172	CbGeAlD
Metformin—NDUFB6—nervous system—acquired immunodeficiency syndrome	0.000377	0.00172	CbGeAlD
Metformin—NDUFA4—lung—acquired immunodeficiency syndrome	0.000376	0.00172	CbGeAlD
Metformin—NDUFV2—brain—acquired immunodeficiency syndrome	0.000375	0.00171	CbGeAlD
Metformin—NDUFAF2—central nervous system—acquired immunodeficiency syndrome	0.000375	0.00171	CbGeAlD
Metformin—NDUFS1—nervous system—acquired immunodeficiency syndrome	0.000375	0.00171	CbGeAlD
Metformin—NDUFV1—lung—acquired immunodeficiency syndrome	0.000374	0.00171	CbGeAlD
Metformin—NDUFB11—lung—acquired immunodeficiency syndrome	0.000374	0.00171	CbGeAlD
Metformin—NDUFB10—nervous system—acquired immunodeficiency syndrome	0.000372	0.0017	CbGeAlD
Metformin—NDUFS5—lung—acquired immunodeficiency syndrome	0.000372	0.0017	CbGeAlD
Metformin—NDUFB8—lung—acquired immunodeficiency syndrome	0.000372	0.0017	CbGeAlD
Metformin—NDUFA12—nervous system—acquired immunodeficiency syndrome	0.000369	0.00169	CbGeAlD
Metformin—NDUFB7—nervous system—acquired immunodeficiency syndrome	0.000369	0.00169	CbGeAlD
Metformin—NDUFS7—vagina—acquired immunodeficiency syndrome	0.000368	0.00168	CbGeAlD
Metformin—SLC29A4—Transport of vitamins, nucleosides, and related molecules—ALB—acquired immunodeficiency syndrome	0.000367	0.04	CbGpPWpGaD
Metformin—NDUFS8—nervous system—acquired immunodeficiency syndrome	0.000367	0.00167	CbGeAlD
Metformin—NDUFB1—nervous system—acquired immunodeficiency syndrome	0.000367	0.00167	CbGeAlD
Metformin—NDUFA11—central nervous system—acquired immunodeficiency syndrome	0.000366	0.00167	CbGeAlD
Metformin—NDUFA5—central nervous system—acquired immunodeficiency syndrome	0.000366	0.00167	CbGeAlD
Metformin—NDUFA4L2—brain—acquired immunodeficiency syndrome	0.000365	0.00167	CbGeAlD
Metformin—NDUFC2—lymphoid tissue—acquired immunodeficiency syndrome	0.000364	0.00166	CbGeAlD
Metformin—NDUFAF4—central nervous system—acquired immunodeficiency syndrome	0.000363	0.00166	CbGeAlD
Metformin—NDUFB6—central nervous system—acquired immunodeficiency syndrome	0.000363	0.00166	CbGeAlD
Metformin—PRKAB1—blood—acquired immunodeficiency syndrome	0.000363	0.00166	CbGeAlD
Metformin—NDUFV2—lymph node—acquired immunodeficiency syndrome	0.000362	0.00165	CbGeAlD
Metformin—NDUFB5—nervous system—acquired immunodeficiency syndrome	0.000362	0.00165	CbGeAlD
Metformin—NDUFA6—nervous system—acquired immunodeficiency syndrome	0.000362	0.00165	CbGeAlD
Metformin—NDUFS1—central nervous system—acquired immunodeficiency syndrome	0.000361	0.00165	CbGeAlD
Metformin—NDUFS4—nervous system—acquired immunodeficiency syndrome	0.000359	0.00164	CbGeAlD
Metformin—NDUFC2—digestive system—acquired immunodeficiency syndrome	0.000359	0.00164	CbGeAlD
Metformin—NDUFB10—central nervous system—acquired immunodeficiency syndrome	0.000358	0.00163	CbGeAlD
Metformin—NDUFA12—central nervous system—acquired immunodeficiency syndrome	0.000356	0.00162	CbGeAlD
Metformin—NDUFB7—central nervous system—acquired immunodeficiency syndrome	0.000356	0.00162	CbGeAlD
Metformin—NDUFB4—nervous system—acquired immunodeficiency syndrome	0.000355	0.00162	CbGeAlD
Metformin—ND1—skin of body—acquired immunodeficiency syndrome	0.000354	0.00162	CbGeAlD
Metformin—NDUFB1—central nervous system—acquired immunodeficiency syndrome	0.000353	0.00161	CbGeAlD
Metformin—NDUFS8—central nervous system—acquired immunodeficiency syndrome	0.000353	0.00161	CbGeAlD
Metformin—NDUFA4L2—lymph node—acquired immunodeficiency syndrome	0.000353	0.00161	CbGeAlD
Metformin—NDUFAB1—nervous system—acquired immunodeficiency syndrome	0.000353	0.00161	CbGeAlD
Metformin—PRKAB1—bone marrow—acquired immunodeficiency syndrome	0.000352	0.0016	CbGeAlD
Metformin—NDUFB9—nervous system—acquired immunodeficiency syndrome	0.00035	0.0016	CbGeAlD
Metformin—NDUFA8—nervous system—acquired immunodeficiency syndrome	0.00035	0.0016	CbGeAlD
Metformin—PRKAB1—spinal cord—acquired immunodeficiency syndrome	0.00035	0.0016	CbGeAlD
Metformin—NDUFS2—lymphoid tissue—acquired immunodeficiency syndrome	0.00035	0.0016	CbGeAlD
Metformin—NDUFB5—central nervous system—acquired immunodeficiency syndrome	0.000348	0.00159	CbGeAlD
Metformin—NDUFA6—central nervous system—acquired immunodeficiency syndrome	0.000348	0.00159	CbGeAlD
Metformin—NDUFA4—nervous system—acquired immunodeficiency syndrome	0.000348	0.00159	CbGeAlD
Metformin—NDUFS7—lung—acquired immunodeficiency syndrome	0.000348	0.00159	CbGeAlD
Metformin—NDUFB11—nervous system—acquired immunodeficiency syndrome	0.000346	0.00158	CbGeAlD
Metformin—NDUFV1—nervous system—acquired immunodeficiency syndrome	0.000346	0.00158	CbGeAlD
Metformin—NDUFS4—central nervous system—acquired immunodeficiency syndrome	0.000346	0.00158	CbGeAlD
Metformin—NDUFS2—digestive system—acquired immunodeficiency syndrome	0.000345	0.00158	CbGeAlD
Metformin—NDUFS3—lymphoid tissue—acquired immunodeficiency syndrome	0.000345	0.00158	CbGeAlD
Metformin—NDUFB8—nervous system—acquired immunodeficiency syndrome	0.000344	0.00157	CbGeAlD
Metformin—NDUFS5—nervous system—acquired immunodeficiency syndrome	0.000344	0.00157	CbGeAlD
Metformin—ND3—brain—acquired immunodeficiency syndrome	0.000343	0.00157	CbGeAlD
Metformin—ND4L—brain—acquired immunodeficiency syndrome	0.000343	0.00157	CbGeAlD
Metformin—ND2—brain—acquired immunodeficiency syndrome	0.000343	0.00157	CbGeAlD
Metformin—ND5—brain—acquired immunodeficiency syndrome	0.000343	0.00157	CbGeAlD
Metformin—NDUFC2—blood—acquired immunodeficiency syndrome	0.000342	0.00156	CbGeAlD
Metformin—NDUFB4—central nervous system—acquired immunodeficiency syndrome	0.000342	0.00156	CbGeAlD
Metformin—NDUFS3—digestive system—acquired immunodeficiency syndrome	0.000341	0.00156	CbGeAlD
Metformin—NDUFAB1—central nervous system—acquired immunodeficiency syndrome	0.000339	0.00155	CbGeAlD
Metformin—NDUFA8—central nervous system—acquired immunodeficiency syndrome	0.000337	0.00154	CbGeAlD
Metformin—NDUFB9—central nervous system—acquired immunodeficiency syndrome	0.000337	0.00154	CbGeAlD
Metformin—PRKAB1—vagina—acquired immunodeficiency syndrome	0.000337	0.00154	CbGeAlD
Metformin—NDUFA4—central nervous system—acquired immunodeficiency syndrome	0.000335	0.00153	CbGeAlD
Metformin—NDUFV1—central nervous system—acquired immunodeficiency syndrome	0.000333	0.00152	CbGeAlD
Metformin—NDUFB11—central nervous system—acquired immunodeficiency syndrome	0.000333	0.00152	CbGeAlD
Metformin—ND4—brain—acquired immunodeficiency syndrome	0.000332	0.00152	CbGeAlD
Metformin—ND4L—lymph node—acquired immunodeficiency syndrome	0.000331	0.00151	CbGeAlD
Metformin—ND5—lymph node—acquired immunodeficiency syndrome	0.000331	0.00151	CbGeAlD
Metformin—ND2—lymph node—acquired immunodeficiency syndrome	0.000331	0.00151	CbGeAlD
Metformin—ND3—lymph node—acquired immunodeficiency syndrome	0.000331	0.00151	CbGeAlD
Metformin—NDUFS5—central nervous system—acquired immunodeficiency syndrome	0.000331	0.00151	CbGeAlD
Metformin—NDUFB8—central nervous system—acquired immunodeficiency syndrome	0.000331	0.00151	CbGeAlD
Metformin—NDUFC2—bone marrow—acquired immunodeficiency syndrome	0.000331	0.00151	CbGeAlD
Metformin—NDUFC2—spinal cord—acquired immunodeficiency syndrome	0.00033	0.00151	CbGeAlD
Metformin—NDUFS2—blood—acquired immunodeficiency syndrome	0.000329	0.0015	CbGeAlD
Metformin—NDUFA2—brain—acquired immunodeficiency syndrome	0.000325	0.00148	CbGeAlD
Metformin—NDUFS3—blood—acquired immunodeficiency syndrome	0.000325	0.00148	CbGeAlD
Metformin—NDUFS7—nervous system—acquired immunodeficiency syndrome	0.000322	0.00147	CbGeAlD
Metformin—ND4—lymph node—acquired immunodeficiency syndrome	0.000321	0.00146	CbGeAlD
Metformin—PRKAB1—lung—acquired immunodeficiency syndrome	0.000318	0.00145	CbGeAlD
Metformin—NDUFS2—bone marrow—acquired immunodeficiency syndrome	0.000318	0.00145	CbGeAlD
Metformin—NDUFC2—vagina—acquired immunodeficiency syndrome	0.000317	0.00145	CbGeAlD
Metformin—NDUFS2—spinal cord—acquired immunodeficiency syndrome	0.000317	0.00145	CbGeAlD
Metformin—NDUFS3—bone marrow—acquired immunodeficiency syndrome	0.000315	0.00144	CbGeAlD
Metformin—NDUFA2—lymph node—acquired immunodeficiency syndrome	0.000314	0.00143	CbGeAlD
Metformin—NDUFS3—spinal cord—acquired immunodeficiency syndrome	0.000313	0.00143	CbGeAlD
Metformin—NDUFS7—central nervous system—acquired immunodeficiency syndrome	0.00031	0.00142	CbGeAlD
Metformin—NDUFA10—brain—acquired immunodeficiency syndrome	0.00031	0.00142	CbGeAlD
Metformin—NDUFC1—brain—acquired immunodeficiency syndrome	0.000308	0.0014	CbGeAlD
Metformin—NDUFS2—vagina—acquired immunodeficiency syndrome	0.000305	0.00139	CbGeAlD
Metformin—NDUFB2—brain—acquired immunodeficiency syndrome	0.000305	0.00139	CbGeAlD
Metformin—NDUFAF1—brain—acquired immunodeficiency syndrome	0.000302	0.00138	CbGeAlD
Metformin—NDUFS3—vagina—acquired immunodeficiency syndrome	0.000301	0.00138	CbGeAlD
Metformin—NDUFC2—lung—acquired immunodeficiency syndrome	0.0003	0.00137	CbGeAlD
Metformin—ND6—brain—acquired immunodeficiency syndrome	0.0003	0.00137	CbGeAlD
Metformin—NDUFA10—lymph node—acquired immunodeficiency syndrome	0.0003	0.00137	CbGeAlD
Metformin—NDUFAF2—brain—acquired immunodeficiency syndrome	0.000297	0.00136	CbGeAlD
Metformin—NDUFB3—brain—acquired immunodeficiency syndrome	0.000297	0.00136	CbGeAlD
Metformin—NDUFC1—lymph node—acquired immunodeficiency syndrome	0.000297	0.00136	CbGeAlD
Metformin—PRKAB1—nervous system—acquired immunodeficiency syndrome	0.000295	0.00135	CbGeAlD
Metformin—NDUFB2—lymph node—acquired immunodeficiency syndrome	0.000295	0.00135	CbGeAlD
Metformin—NDUFAF1—lymph node—acquired immunodeficiency syndrome	0.000292	0.00133	CbGeAlD
Metformin—NDUFA5—brain—acquired immunodeficiency syndrome	0.000291	0.00133	CbGeAlD
Metformin—NDUFA11—brain—acquired immunodeficiency syndrome	0.000291	0.00133	CbGeAlD
Metformin—ND6—lymph node—acquired immunodeficiency syndrome	0.00029	0.00132	CbGeAlD
Metformin—NDUFS2—lung—acquired immunodeficiency syndrome	0.000289	0.00132	CbGeAlD
Metformin—NDUFAF4—brain—acquired immunodeficiency syndrome	0.000288	0.00132	CbGeAlD
Metformin—NDUFB6—brain—acquired immunodeficiency syndrome	0.000288	0.00132	CbGeAlD
Metformin—NDUFB3—lymph node—acquired immunodeficiency syndrome	0.000287	0.00131	CbGeAlD
Metformin—NDUFAF2—lymph node—acquired immunodeficiency syndrome	0.000287	0.00131	CbGeAlD
Metformin—ND1—lymphoid tissue—acquired immunodeficiency syndrome	0.000287	0.00131	CbGeAlD
Metformin—NDUFS1—brain—acquired immunodeficiency syndrome	0.000286	0.00131	CbGeAlD
Metformin—NDUFS3—lung—acquired immunodeficiency syndrome	0.000285	0.0013	CbGeAlD
Metformin—NDUFB10—brain—acquired immunodeficiency syndrome	0.000284	0.0013	CbGeAlD
Metformin—PRKAB1—central nervous system—acquired immunodeficiency syndrome	0.000284	0.0013	CbGeAlD
Metformin—ND1—digestive system—acquired immunodeficiency syndrome	0.000283	0.00129	CbGeAlD
Metformin—NDUFA12—brain—acquired immunodeficiency syndrome	0.000282	0.00129	CbGeAlD
Metformin—NDUFB7—brain—acquired immunodeficiency syndrome	0.000282	0.00129	CbGeAlD
Metformin—NDUFA5—lymph node—acquired immunodeficiency syndrome	0.000281	0.00128	CbGeAlD
Metformin—NDUFA11—lymph node—acquired immunodeficiency syndrome	0.000281	0.00128	CbGeAlD
Metformin—NDUFB1—brain—acquired immunodeficiency syndrome	0.00028	0.00128	CbGeAlD
Metformin—NDUFS8—brain—acquired immunodeficiency syndrome	0.00028	0.00128	CbGeAlD
Metformin—NDUFAF4—lymph node—acquired immunodeficiency syndrome	0.000279	0.00127	CbGeAlD
Metformin—NDUFB6—lymph node—acquired immunodeficiency syndrome	0.000279	0.00127	CbGeAlD
Metformin—NDUFC2—nervous system—acquired immunodeficiency syndrome	0.000278	0.00127	CbGeAlD
Metformin—NDUFS1—lymph node—acquired immunodeficiency syndrome	0.000277	0.00126	CbGeAlD
Metformin—NDUFB5—brain—acquired immunodeficiency syndrome	0.000277	0.00126	CbGeAlD
Metformin—NDUFA6—brain—acquired immunodeficiency syndrome	0.000277	0.00126	CbGeAlD
Metformin—NDUFS4—brain—acquired immunodeficiency syndrome	0.000275	0.00125	CbGeAlD
Metformin—NDUFB10—lymph node—acquired immunodeficiency syndrome	0.000275	0.00125	CbGeAlD
Metformin—NDUFA12—lymph node—acquired immunodeficiency syndrome	0.000273	0.00125	CbGeAlD
Metformin—NDUFB7—lymph node—acquired immunodeficiency syndrome	0.000273	0.00125	CbGeAlD
Metformin—NDUFB4—brain—acquired immunodeficiency syndrome	0.000271	0.00124	CbGeAlD
Metformin—NDUFS8—lymph node—acquired immunodeficiency syndrome	0.000271	0.00124	CbGeAlD
Metformin—NDUFB1—lymph node—acquired immunodeficiency syndrome	0.000271	0.00124	CbGeAlD
Metformin—NDUFAB1—brain—acquired immunodeficiency syndrome	0.000269	0.00123	CbGeAlD
Metformin—NDUFA8—brain—acquired immunodeficiency syndrome	0.000268	0.00122	CbGeAlD
Metformin—NDUFB9—brain—acquired immunodeficiency syndrome	0.000268	0.00122	CbGeAlD
Metformin—NDUFC2—central nervous system—acquired immunodeficiency syndrome	0.000268	0.00122	CbGeAlD
Metformin—NDUFB5—lymph node—acquired immunodeficiency syndrome	0.000267	0.00122	CbGeAlD
Metformin—NDUFA6—lymph node—acquired immunodeficiency syndrome	0.000267	0.00122	CbGeAlD
Metformin—NDUFS2—nervous system—acquired immunodeficiency syndrome	0.000267	0.00122	CbGeAlD
Metformin—NDUFA4—brain—acquired immunodeficiency syndrome	0.000266	0.00122	CbGeAlD
Metformin—NDUFS4—lymph node—acquired immunodeficiency syndrome	0.000265	0.00121	CbGeAlD
Metformin—NDUFV1—brain—acquired immunodeficiency syndrome	0.000265	0.00121	CbGeAlD
Metformin—NDUFB11—brain—acquired immunodeficiency syndrome	0.000265	0.00121	CbGeAlD
Metformin—NDUFS3—nervous system—acquired immunodeficiency syndrome	0.000264	0.0012	CbGeAlD
Metformin—NDUFB8—brain—acquired immunodeficiency syndrome	0.000263	0.0012	CbGeAlD
Metformin—NDUFS5—brain—acquired immunodeficiency syndrome	0.000263	0.0012	CbGeAlD
Metformin—NDUFB4—lymph node—acquired immunodeficiency syndrome	0.000262	0.0012	CbGeAlD
Metformin—ND1—bone marrow—acquired immunodeficiency syndrome	0.000261	0.00119	CbGeAlD
Metformin—NDUFAB1—lymph node—acquired immunodeficiency syndrome	0.00026	0.00119	CbGeAlD
Metformin—NDUFA8—lymph node—acquired immunodeficiency syndrome	0.000259	0.00118	CbGeAlD
Metformin—NDUFB9—lymph node—acquired immunodeficiency syndrome	0.000259	0.00118	CbGeAlD
Metformin—NDUFS2—central nervous system—acquired immunodeficiency syndrome	0.000257	0.00117	CbGeAlD
Metformin—NDUFA4—lymph node—acquired immunodeficiency syndrome	0.000257	0.00117	CbGeAlD
Metformin—NDUFV1—lymph node—acquired immunodeficiency syndrome	0.000256	0.00117	CbGeAlD
Metformin—NDUFB11—lymph node—acquired immunodeficiency syndrome	0.000256	0.00117	CbGeAlD
Metformin—NDUFS5—lymph node—acquired immunodeficiency syndrome	0.000254	0.00116	CbGeAlD
Metformin—NDUFB8—lymph node—acquired immunodeficiency syndrome	0.000254	0.00116	CbGeAlD
Metformin—NDUFS3—central nervous system—acquired immunodeficiency syndrome	0.000254	0.00116	CbGeAlD
Metformin—NDUFS7—brain—acquired immunodeficiency syndrome	0.000246	0.00113	CbGeAlD
Metformin—NDUFS7—lymph node—acquired immunodeficiency syndrome	0.000238	0.00109	CbGeAlD
Metformin—ND1—lung—acquired immunodeficiency syndrome	0.000237	0.00108	CbGeAlD
Metformin—SLC22A2—digestive system—acquired immunodeficiency syndrome	0.000227	0.00104	CbGeAlD
Metformin—PRKAB1—brain—acquired immunodeficiency syndrome	0.000225	0.00103	CbGeAlD
Metformin—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.000222	0.000868	CcSEcCtD
Metformin—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000222	0.000868	CcSEcCtD
Metformin—Syncope—Ritonavir—acquired immunodeficiency syndrome	0.000222	0.000867	CcSEcCtD
Metformin—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.000221	0.000866	CcSEcCtD
Metformin—Ill-defined disorder—Saquinavir—acquired immunodeficiency syndrome	0.000221	0.000863	CcSEcCtD
Metformin—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.00022	0.000862	CcSEcCtD
Metformin—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.00022	0.00086	CcSEcCtD
Metformin—ND1—nervous system—acquired immunodeficiency syndrome	0.000219	0.001	CbGeAlD
Metformin—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000219	0.000856	CcSEcCtD
Metformin—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000219	0.000855	CcSEcCtD
Metformin—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.000218	0.000854	CcSEcCtD
Metformin—Muscle spasms—Lamivudine—acquired immunodeficiency syndrome	0.000218	0.000853	CcSEcCtD
Metformin—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.000218	0.000853	CcSEcCtD
Metformin—PRKAB1—lymph node—acquired immunodeficiency syndrome	0.000218	0.000994	CbGeAlD
Metformin—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000217	0.00085	CcSEcCtD
Metformin—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.000217	0.00085	CcSEcCtD
Metformin—Rash—Didanosine—acquired immunodeficiency syndrome	0.000217	0.000848	CcSEcCtD
Metformin—Infection—Delavirdine—acquired immunodeficiency syndrome	0.000217	0.000848	CcSEcCtD
Metformin—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000217	0.000847	CcSEcCtD
Metformin—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000217	0.000847	CcSEcCtD
Metformin—Headache—Didanosine—acquired immunodeficiency syndrome	0.000215	0.000842	CcSEcCtD
Metformin—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000215	0.000841	CcSEcCtD
Metformin—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000215	0.00084	CcSEcCtD
Metformin—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000215	0.000839	CcSEcCtD
Metformin—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.000215	0.000839	CcSEcCtD
Metformin—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000214	0.000839	CcSEcCtD
Metformin—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000214	0.000838	CcSEcCtD
Metformin—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000214	0.000836	CcSEcCtD
Metformin—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000214	0.000835	CcSEcCtD
Metformin—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000213	0.000835	CcSEcCtD
Metformin—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000213	0.000834	CcSEcCtD
Metformin—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000213	0.000832	CcSEcCtD
Metformin—NDUFC2—brain—acquired immunodeficiency syndrome	0.000212	0.00097	CbGeAlD
Metformin—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000212	0.000831	CcSEcCtD
Metformin—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000212	0.00083	CcSEcCtD
Metformin—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000212	0.000829	CcSEcCtD
Metformin—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000212	0.000829	CcSEcCtD
Metformin—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000212	0.000827	CcSEcCtD
Metformin—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000211	0.000826	CcSEcCtD
Metformin—ND1—central nervous system—acquired immunodeficiency syndrome	0.000211	0.000963	CbGeAlD
Metformin—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000211	0.000825	CcSEcCtD
Metformin—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000211	0.000825	CcSEcCtD
Metformin—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000211	0.000824	CcSEcCtD
Metformin—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.00021	0.000823	CcSEcCtD
Metformin—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.00021	0.000823	CcSEcCtD
Metformin—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.00021	0.00082	CcSEcCtD
Metformin—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000209	0.000818	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000209	0.000817	CcSEcCtD
Metformin—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000208	0.000815	CcSEcCtD
Metformin—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000208	0.000814	CcSEcCtD
Metformin—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000208	0.000814	CcSEcCtD
Metformin—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000208	0.000813	CcSEcCtD
Metformin—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000208	0.000813	CcSEcCtD
Metformin—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000208	0.000812	CcSEcCtD
Metformin—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000206	0.000807	CcSEcCtD
Metformin—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000206	0.000806	CcSEcCtD
Metformin—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000205	0.000803	CcSEcCtD
Metformin—NDUFC2—lymph node—acquired immunodeficiency syndrome	0.000205	0.000937	CbGeAlD
Metformin—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000205	0.000802	CcSEcCtD
Metformin—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000205	0.000801	CcSEcCtD
Metformin—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000205	0.000801	CcSEcCtD
Metformin—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000205	0.0008	CcSEcCtD
Metformin—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000204	0.000799	CcSEcCtD
Metformin—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000204	0.000799	CcSEcCtD
Metformin—NDUFS2—brain—acquired immunodeficiency syndrome	0.000204	0.000932	CbGeAlD
Metformin—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000204	0.000797	CcSEcCtD
Metformin—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000203	0.000796	CcSEcCtD
Metformin—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000203	0.000795	CcSEcCtD
Metformin—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000203	0.000793	CcSEcCtD
Metformin—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000203	0.000792	CcSEcCtD
Metformin—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000203	0.000792	CcSEcCtD
Metformin—NDUFS3—brain—acquired immunodeficiency syndrome	0.000202	0.000921	CbGeAlD
Metformin—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000202	0.000789	CcSEcCtD
Metformin—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000201	0.000787	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000201	0.000787	CcSEcCtD
Metformin—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000201	0.000785	CcSEcCtD
Metformin—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.0002	0.000783	CcSEcCtD
Metformin—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000199	0.00078	CcSEcCtD
Metformin—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000199	0.000778	CcSEcCtD
Metformin—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000199	0.000777	CcSEcCtD
Metformin—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000198	0.000776	CcSEcCtD
Metformin—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000198	0.000775	CcSEcCtD
Metformin—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000198	0.000774	CcSEcCtD
Metformin—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000198	0.000774	CcSEcCtD
Metformin—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000197	0.000772	CcSEcCtD
Metformin—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000197	0.000772	CcSEcCtD
Metformin—NDUFS2—lymph node—acquired immunodeficiency syndrome	0.000197	0.000901	CbGeAlD
Metformin—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000197	0.000772	CcSEcCtD
Metformin—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000197	0.00077	CcSEcCtD
Metformin—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000197	0.000769	CcSEcCtD
Metformin—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000197	0.000769	CcSEcCtD
Metformin—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000196	0.000766	CcSEcCtD
Metformin—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000196	0.000766	CcSEcCtD
Metformin—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000195	0.000763	CcSEcCtD
Metformin—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000195	0.000762	CcSEcCtD
Metformin—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000195	0.000762	CcSEcCtD
Metformin—NDUFS3—lymph node—acquired immunodeficiency syndrome	0.000195	0.00089	CbGeAlD
Metformin—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000195	0.000762	CcSEcCtD
Metformin—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000194	0.000761	CcSEcCtD
Metformin—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000194	0.000761	CcSEcCtD
Metformin—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000194	0.000759	CcSEcCtD
Metformin—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000194	0.000758	CcSEcCtD
Metformin—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000194	0.000758	CcSEcCtD
Metformin—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000193	0.000756	CcSEcCtD
Metformin—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000193	0.000756	CcSEcCtD
Metformin—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000193	0.000754	CcSEcCtD
Metformin—SLC47A1—digestive system—acquired immunodeficiency syndrome	0.000193	0.000879	CbGeAlD
Metformin—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000192	0.000752	CcSEcCtD
Metformin—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000192	0.000751	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000192	0.00075	CcSEcCtD
Metformin—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000192	0.00075	CcSEcCtD
Metformin—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000191	0.000747	CcSEcCtD
Metformin—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000191	0.000747	CcSEcCtD
Metformin—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000191	0.000746	CcSEcCtD
Metformin—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.00019	0.000745	CcSEcCtD
Metformin—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.00019	0.000745	CcSEcCtD
Metformin—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.00019	0.000743	CcSEcCtD
Metformin—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.00019	0.000742	CcSEcCtD
Metformin—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.00019	0.000742	CcSEcCtD
Metformin—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000189	0.000738	CcSEcCtD
Metformin—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000189	0.000738	CcSEcCtD
Metformin—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000189	0.000738	CcSEcCtD
Metformin—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000188	0.000737	CcSEcCtD
Metformin—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000188	0.000737	CcSEcCtD
Metformin—Rash—Stavudine—acquired immunodeficiency syndrome	0.000188	0.000736	CcSEcCtD
Metformin—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000188	0.000736	CcSEcCtD
Metformin—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000188	0.000735	CcSEcCtD
Metformin—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000188	0.000735	CcSEcCtD
Metformin—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000188	0.000734	CcSEcCtD
Metformin—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000188	0.000734	CcSEcCtD
Metformin—Headache—Stavudine—acquired immunodeficiency syndrome	0.000187	0.000731	CcSEcCtD
Metformin—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000187	0.000731	CcSEcCtD
Metformin—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000187	0.00073	CcSEcCtD
Metformin—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000186	0.000729	CcSEcCtD
Metformin—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000186	0.000728	CcSEcCtD
Metformin—Rash—Abacavir—acquired immunodeficiency syndrome	0.000185	0.000725	CcSEcCtD
Metformin—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000185	0.000725	CcSEcCtD
Metformin—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000185	0.000724	CcSEcCtD
Metformin—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000185	0.000724	CcSEcCtD
Metformin—Headache—Abacavir—acquired immunodeficiency syndrome	0.000184	0.000721	CcSEcCtD
Metformin—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000184	0.00072	CcSEcCtD
Metformin—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000184	0.000719	CcSEcCtD
Metformin—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000184	0.000718	CcSEcCtD
Metformin—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000184	0.000718	CcSEcCtD
Metformin—SLC47A1—blood—acquired immunodeficiency syndrome	0.000183	0.000837	CbGeAlD
Metformin—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000182	0.000713	CcSEcCtD
Metformin—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000182	0.00071	CcSEcCtD
Metformin—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000181	0.00071	CcSEcCtD
Metformin—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000181	0.000709	CcSEcCtD
Metformin—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000181	0.000708	CcSEcCtD
Metformin—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000181	0.000708	CcSEcCtD
Metformin—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.00018	0.000705	CcSEcCtD
Metformin—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.00018	0.000704	CcSEcCtD
Metformin—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.00018	0.000703	CcSEcCtD
Metformin—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.00018	0.000703	CcSEcCtD
Metformin—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000179	0.000701	CcSEcCtD
Metformin—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000179	0.0007	CcSEcCtD
Metformin—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000178	0.000698	CcSEcCtD
Metformin—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000178	0.000696	CcSEcCtD
Metformin—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000178	0.000694	CcSEcCtD
Metformin—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000178	0.000694	CcSEcCtD
Metformin—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000177	0.000693	CcSEcCtD
Metformin—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000177	0.000692	CcSEcCtD
Metformin—SLC47A1—spinal cord—acquired immunodeficiency syndrome	0.000177	0.000807	CbGeAlD
Metformin—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000177	0.000691	CcSEcCtD
Metformin—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000175	0.000686	CcSEcCtD
Metformin—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000175	0.000683	CcSEcCtD
Metformin—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000174	0.000682	CcSEcCtD
Metformin—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000174	0.000681	CcSEcCtD
Metformin—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000174	0.00068	CcSEcCtD
Metformin—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000173	0.000678	CcSEcCtD
Metformin—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000173	0.000677	CcSEcCtD
Metformin—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000173	0.000677	CcSEcCtD
Metformin—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000173	0.000677	CcSEcCtD
Metformin—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000173	0.000675	CcSEcCtD
Metformin—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000172	0.000675	CcSEcCtD
Metformin—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000172	0.000674	CcSEcCtD
Metformin—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000172	0.000671	CcSEcCtD
Metformin—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000171	0.000668	CcSEcCtD
Metformin—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000171	0.000668	CcSEcCtD
Metformin—SLC47A1—vagina—acquired immunodeficiency syndrome	0.00017	0.000776	CbGeAlD
Metformin—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000169	0.00066	CcSEcCtD
Metformin—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000169	0.00066	CcSEcCtD
Metformin—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000168	0.000656	CcSEcCtD
Metformin—ND1—brain—acquired immunodeficiency syndrome	0.000168	0.000765	CbGeAlD
Metformin—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000167	0.000655	CcSEcCtD
Metformin—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000166	0.00065	CcSEcCtD
Metformin—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000166	0.00065	CcSEcCtD
Metformin—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000166	0.000649	CcSEcCtD
Metformin—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000165	0.000646	CcSEcCtD
Metformin—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000165	0.000646	CcSEcCtD
Metformin—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000165	0.000645	CcSEcCtD
Metformin—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000165	0.000645	CcSEcCtD
Metformin—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000165	0.000644	CcSEcCtD
Metformin—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000164	0.00064	CcSEcCtD
Metformin—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000164	0.00064	CcSEcCtD
Metformin—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000163	0.000639	CcSEcCtD
Metformin—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000163	0.000638	CcSEcCtD
Metformin—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000163	0.000636	CcSEcCtD
Metformin—ND1—lymph node—acquired immunodeficiency syndrome	0.000162	0.000739	CbGeAlD
Metformin—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000161	0.000631	CcSEcCtD
Metformin—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000161	0.00063	CcSEcCtD
Metformin—SLC47A1—lung—acquired immunodeficiency syndrome	0.000161	0.000734	CbGeAlD
Metformin—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.00016	0.000627	CcSEcCtD
Metformin—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.00016	0.000626	CcSEcCtD
Metformin—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.00016	0.000625	CcSEcCtD
Metformin—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.00016	0.000625	CcSEcCtD
Metformin—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.00016	0.000624	CcSEcCtD
Metformin—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000159	0.000624	CcSEcCtD
Metformin—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000159	0.000621	CcSEcCtD
Metformin—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000158	0.000619	CcSEcCtD
Metformin—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000156	0.000612	CcSEcCtD
Metformin—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000156	0.00061	CcSEcCtD
Metformin—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000154	0.000604	CcSEcCtD
Metformin—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000154	0.000603	CcSEcCtD
Metformin—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000154	0.000603	CcSEcCtD
Metformin—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000153	0.0006	CcSEcCtD
Metformin—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000153	0.0006	CcSEcCtD
Metformin—SLC22A1—blood—acquired immunodeficiency syndrome	0.000153	0.000699	CbGeAlD
Metformin—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000153	0.000597	CcSEcCtD
Metformin—Rash—Indinavir—acquired immunodeficiency syndrome	0.000152	0.000595	CcSEcCtD
Metformin—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000152	0.000594	CcSEcCtD
Metformin—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000151	0.000592	CcSEcCtD
Metformin—Headache—Indinavir—acquired immunodeficiency syndrome	0.000151	0.000591	CcSEcCtD
Metformin—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000151	0.00059	CcSEcCtD
Metformin—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000149	0.000584	CcSEcCtD
Metformin—SLC47A1—nervous system—acquired immunodeficiency syndrome	0.000149	0.00068	CbGeAlD
Metformin—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000147	0.000575	CcSEcCtD
Metformin—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000146	0.000573	CcSEcCtD
Metformin—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000145	0.000567	CcSEcCtD
Metformin—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000145	0.000566	CcSEcCtD
Metformin—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000144	0.000564	CcSEcCtD
Metformin—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000144	0.000562	CcSEcCtD
Metformin—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000144	0.000562	CcSEcCtD
Metformin—SLC47A1—central nervous system—acquired immunodeficiency syndrome	0.000143	0.000655	CbGeAlD
Metformin—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000143	0.000561	CcSEcCtD
Metformin—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000143	0.000559	CcSEcCtD
Metformin—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000143	0.000558	CcSEcCtD
Metformin—SLC22A1—vagina—acquired immunodeficiency syndrome	0.000142	0.000648	CbGeAlD
Metformin—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000139	0.000545	CcSEcCtD
Metformin—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000139	0.000542	CcSEcCtD
Metformin—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000138	0.00054	CcSEcCtD
Metformin—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000138	0.000538	CcSEcCtD
Metformin—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000137	0.000537	CcSEcCtD
Metformin—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000137	0.000537	CcSEcCtD
Metformin—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000137	0.000534	CcSEcCtD
Metformin—SLC22A3—vagina—acquired immunodeficiency syndrome	0.000136	0.000619	CbGeAlD
Metformin—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000135	0.00053	CcSEcCtD
Metformin—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000133	0.000522	CcSEcCtD
Metformin—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000133	0.00052	CcSEcCtD
Metformin—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000133	0.00052	CcSEcCtD
Metformin—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000131	0.000513	CcSEcCtD
Metformin—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.00013	0.000507	CcSEcCtD
Metformin—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000128	0.000502	CcSEcCtD
Metformin—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000128	0.000502	CcSEcCtD
Metformin—SLC22A3—lung—acquired immunodeficiency syndrome	0.000128	0.000585	CbGeAlD
Metformin—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000127	0.000497	CcSEcCtD
Metformin—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000127	0.000497	CcSEcCtD
Metformin—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000127	0.000496	CcSEcCtD
Metformin—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000126	0.000494	CcSEcCtD
Metformin—SLC22A1—nervous system—acquired immunodeficiency syndrome	0.000124	0.000567	CbGeAlD
Metformin—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000123	0.000483	CcSEcCtD
Metformin—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000122	0.000479	CcSEcCtD
Metformin—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000122	0.000479	CcSEcCtD
Metformin—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000122	0.000478	CcSEcCtD
Metformin—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000122	0.000476	CcSEcCtD
Metformin—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.00012	0.000469	CcSEcCtD
Metformin—SLC22A1—central nervous system—acquired immunodeficiency syndrome	0.00012	0.000546	CbGeAlD
Metformin—SLC22A3—nervous system—acquired immunodeficiency syndrome	0.000119	0.000542	CbGeAlD
Metformin—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000118	0.000461	CcSEcCtD
Metformin—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000117	0.000457	CcSEcCtD
Metformin—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000117	0.000456	CcSEcCtD
Metformin—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000116	0.000454	CcSEcCtD
Metformin—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000115	0.000451	CcSEcCtD
Metformin—SLC22A3—central nervous system—acquired immunodeficiency syndrome	0.000114	0.000522	CbGeAlD
Metformin—SLC47A1—brain—acquired immunodeficiency syndrome	0.000114	0.00052	CbGeAlD
Metformin—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.00011	0.00043	CcSEcCtD
Metformin—SLC47A1—lymph node—acquired immunodeficiency syndrome	0.00011	0.000502	CbGeAlD
Metformin—NDUFB11—Metabolism—TAT—acquired immunodeficiency syndrome	0.000108	0.0117	CbGpPWpGaD
Metformin—NDUFA11—Metabolism—TAT—acquired immunodeficiency syndrome	9.85e-05	0.0107	CbGpPWpGaD
Metformin—NDUFA12—Metabolism—TAT—acquired immunodeficiency syndrome	9.85e-05	0.0107	CbGpPWpGaD
Metformin—NDUFA1—Metabolism—TAT—acquired immunodeficiency syndrome	9.85e-05	0.0107	CbGpPWpGaD
Metformin—NDUFB3—Metabolism—TAT—acquired immunodeficiency syndrome	9.85e-05	0.0107	CbGpPWpGaD
Metformin—SLC22A1—brain—acquired immunodeficiency syndrome	9.5e-05	0.000434	CbGeAlD
Metformin—NDUFA10—Metabolism—TAT—acquired immunodeficiency syndrome	9.15e-05	0.00996	CbGpPWpGaD
Metformin—NDUFB10—Metabolism—TAT—acquired immunodeficiency syndrome	9.15e-05	0.00996	CbGpPWpGaD
Metformin—NDUFA8—Metabolism—TAT—acquired immunodeficiency syndrome	9.15e-05	0.00996	CbGpPWpGaD
Metformin—NDUFA2—Metabolism—TAT—acquired immunodeficiency syndrome	9.15e-05	0.00996	CbGpPWpGaD
Metformin—NDUFB8—Metabolism—TAT—acquired immunodeficiency syndrome	9.15e-05	0.00996	CbGpPWpGaD
Metformin—NDUFS8—Metabolism—TAT—acquired immunodeficiency syndrome	9.15e-05	0.00996	CbGpPWpGaD
Metformin—NDUFB9—Metabolism—TAT—acquired immunodeficiency syndrome	9.15e-05	0.00996	CbGpPWpGaD
Metformin—NDUFAB1—Metabolism—TAT—acquired immunodeficiency syndrome	9.15e-05	0.00996	CbGpPWpGaD
Metformin—NDUFS1—Metabolism—TAT—acquired immunodeficiency syndrome	9.15e-05	0.00996	CbGpPWpGaD
Metformin—NDUFC1—Metabolism—TAT—acquired immunodeficiency syndrome	9.15e-05	0.00996	CbGpPWpGaD
Metformin—NDUFA13—Metabolism—TAT—acquired immunodeficiency syndrome	9.15e-05	0.00996	CbGpPWpGaD
Metformin—NDUFS5—Metabolism—TAT—acquired immunodeficiency syndrome	9.15e-05	0.00996	CbGpPWpGaD
Metformin—ND4—Metabolism—TAT—acquired immunodeficiency syndrome	9.15e-05	0.00996	CbGpPWpGaD
Metformin—NDUFB5—Metabolism—TAT—acquired immunodeficiency syndrome	9.15e-05	0.00996	CbGpPWpGaD
Metformin—NDUFS4—Metabolism—TAT—acquired immunodeficiency syndrome	9.15e-05	0.00996	CbGpPWpGaD
Metformin—NDUFB4—Metabolism—TAT—acquired immunodeficiency syndrome	9.15e-05	0.00996	CbGpPWpGaD
Metformin—ND3—Metabolism—TAT—acquired immunodeficiency syndrome	9.15e-05	0.00996	CbGpPWpGaD
Metformin—NDUFB1—Metabolism—TAT—acquired immunodeficiency syndrome	9.15e-05	0.00996	CbGpPWpGaD
Metformin—ND2—Metabolism—TAT—acquired immunodeficiency syndrome	9.15e-05	0.00996	CbGpPWpGaD
Metformin—NDUFA3—Metabolism—TAT—acquired immunodeficiency syndrome	9.15e-05	0.00996	CbGpPWpGaD
Metformin—NDUFV2—Metabolism—TAT—acquired immunodeficiency syndrome	9.15e-05	0.00996	CbGpPWpGaD
Metformin—NDUFS6—Metabolism—TAT—acquired immunodeficiency syndrome	9.15e-05	0.00996	CbGpPWpGaD
Metformin—NDUFA7—Metabolism—TAT—acquired immunodeficiency syndrome	9.15e-05	0.00996	CbGpPWpGaD
Metformin—NDUFB6—Metabolism—TAT—acquired immunodeficiency syndrome	9.15e-05	0.00996	CbGpPWpGaD
Metformin—NDUFB2—Metabolism—TAT—acquired immunodeficiency syndrome	9.15e-05	0.00996	CbGpPWpGaD
Metformin—NDUFA9—Metabolism—TAT—acquired immunodeficiency syndrome	9.15e-05	0.00996	CbGpPWpGaD
Metformin—NDUFA4—Metabolism—TAT—acquired immunodeficiency syndrome	9.15e-05	0.00996	CbGpPWpGaD
Metformin—ND5—Metabolism—TAT—acquired immunodeficiency syndrome	9.15e-05	0.00996	CbGpPWpGaD
Metformin—ND4L—Metabolism—TAT—acquired immunodeficiency syndrome	9.15e-05	0.00996	CbGpPWpGaD
Metformin—NDUFA6—Metabolism—TAT—acquired immunodeficiency syndrome	9.15e-05	0.00996	CbGpPWpGaD
Metformin—ND6—Metabolism—TAT—acquired immunodeficiency syndrome	9.15e-05	0.00996	CbGpPWpGaD
Metformin—NDUFA5—Metabolism—TAT—acquired immunodeficiency syndrome	9.15e-05	0.00996	CbGpPWpGaD
Metformin—NDUFV1—Metabolism—TAT—acquired immunodeficiency syndrome	9.15e-05	0.00996	CbGpPWpGaD
Metformin—NDUFB11—Metabolism—AGPS—acquired immunodeficiency syndrome	9.15e-05	0.00996	CbGpPWpGaD
Metformin—NDUFB7—Metabolism—TAT—acquired immunodeficiency syndrome	9.15e-05	0.00996	CbGpPWpGaD
Metformin—SLC22A3—brain—acquired immunodeficiency syndrome	9.08e-05	0.000414	CbGeAlD
Metformin—SLC22A3—lymph node—acquired immunodeficiency syndrome	8.77e-05	0.0004	CbGeAlD
Metformin—NDUFA11—Metabolism—AGPS—acquired immunodeficiency syndrome	8.37e-05	0.00911	CbGpPWpGaD
Metformin—NDUFA12—Metabolism—AGPS—acquired immunodeficiency syndrome	8.37e-05	0.00911	CbGpPWpGaD
Metformin—NDUFA1—Metabolism—AGPS—acquired immunodeficiency syndrome	8.37e-05	0.00911	CbGpPWpGaD
Metformin—NDUFB3—Metabolism—AGPS—acquired immunodeficiency syndrome	8.37e-05	0.00911	CbGpPWpGaD
Metformin—NDUFV3—Metabolism—TAT—acquired immunodeficiency syndrome	8.16e-05	0.00888	CbGpPWpGaD
Metformin—SLC29A4—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	7.89e-05	0.00858	CbGpPWpGaD
Metformin—NDUFA9—Metabolism—AGPS—acquired immunodeficiency syndrome	7.78e-05	0.00847	CbGpPWpGaD
Metformin—NDUFA2—Metabolism—AGPS—acquired immunodeficiency syndrome	7.78e-05	0.00847	CbGpPWpGaD
Metformin—NDUFB6—Metabolism—AGPS—acquired immunodeficiency syndrome	7.78e-05	0.00847	CbGpPWpGaD
Metformin—ND4—Metabolism—AGPS—acquired immunodeficiency syndrome	7.78e-05	0.00847	CbGpPWpGaD
Metformin—NDUFB10—Metabolism—AGPS—acquired immunodeficiency syndrome	7.78e-05	0.00847	CbGpPWpGaD
Metformin—NDUFA7—Metabolism—AGPS—acquired immunodeficiency syndrome	7.78e-05	0.00847	CbGpPWpGaD
Metformin—NDUFB7—Metabolism—AGPS—acquired immunodeficiency syndrome	7.78e-05	0.00847	CbGpPWpGaD
Metformin—NDUFV1—Metabolism—AGPS—acquired immunodeficiency syndrome	7.78e-05	0.00847	CbGpPWpGaD
Metformin—NDUFA5—Metabolism—AGPS—acquired immunodeficiency syndrome	7.78e-05	0.00847	CbGpPWpGaD
Metformin—ND3—Metabolism—AGPS—acquired immunodeficiency syndrome	7.78e-05	0.00847	CbGpPWpGaD
Metformin—ND4L—Metabolism—AGPS—acquired immunodeficiency syndrome	7.78e-05	0.00847	CbGpPWpGaD
Metformin—ND5—Metabolism—AGPS—acquired immunodeficiency syndrome	7.78e-05	0.00847	CbGpPWpGaD
Metformin—NDUFA6—Metabolism—AGPS—acquired immunodeficiency syndrome	7.78e-05	0.00847	CbGpPWpGaD
Metformin—NDUFA4—Metabolism—AGPS—acquired immunodeficiency syndrome	7.78e-05	0.00847	CbGpPWpGaD
Metformin—NDUFB2—Metabolism—AGPS—acquired immunodeficiency syndrome	7.78e-05	0.00847	CbGpPWpGaD
Metformin—NDUFS6—Metabolism—AGPS—acquired immunodeficiency syndrome	7.78e-05	0.00847	CbGpPWpGaD
Metformin—NDUFV2—Metabolism—AGPS—acquired immunodeficiency syndrome	7.78e-05	0.00847	CbGpPWpGaD
Metformin—NDUFA13—Metabolism—AGPS—acquired immunodeficiency syndrome	7.78e-05	0.00847	CbGpPWpGaD
Metformin—NDUFS4—Metabolism—AGPS—acquired immunodeficiency syndrome	7.78e-05	0.00847	CbGpPWpGaD
Metformin—NDUFA3—Metabolism—AGPS—acquired immunodeficiency syndrome	7.78e-05	0.00847	CbGpPWpGaD
Metformin—NDUFB8—Metabolism—AGPS—acquired immunodeficiency syndrome	7.78e-05	0.00847	CbGpPWpGaD
Metformin—NDUFA8—Metabolism—AGPS—acquired immunodeficiency syndrome	7.78e-05	0.00847	CbGpPWpGaD
Metformin—NDUFS8—Metabolism—AGPS—acquired immunodeficiency syndrome	7.78e-05	0.00847	CbGpPWpGaD
Metformin—NDUFA10—Metabolism—AGPS—acquired immunodeficiency syndrome	7.78e-05	0.00847	CbGpPWpGaD
Metformin—NDUFAB1—Metabolism—AGPS—acquired immunodeficiency syndrome	7.78e-05	0.00847	CbGpPWpGaD
Metformin—NDUFB4—Metabolism—AGPS—acquired immunodeficiency syndrome	7.78e-05	0.00847	CbGpPWpGaD
Metformin—ND6—Metabolism—AGPS—acquired immunodeficiency syndrome	7.78e-05	0.00847	CbGpPWpGaD
Metformin—NDUFC1—Metabolism—AGPS—acquired immunodeficiency syndrome	7.78e-05	0.00847	CbGpPWpGaD
Metformin—NDUFB9—Metabolism—AGPS—acquired immunodeficiency syndrome	7.78e-05	0.00847	CbGpPWpGaD
Metformin—NDUFS5—Metabolism—AGPS—acquired immunodeficiency syndrome	7.78e-05	0.00847	CbGpPWpGaD
Metformin—NDUFB5—Metabolism—AGPS—acquired immunodeficiency syndrome	7.78e-05	0.00847	CbGpPWpGaD
Metformin—NDUFB1—Metabolism—AGPS—acquired immunodeficiency syndrome	7.78e-05	0.00847	CbGpPWpGaD
Metformin—NDUFS1—Metabolism—AGPS—acquired immunodeficiency syndrome	7.78e-05	0.00847	CbGpPWpGaD
Metformin—ND2—Metabolism—AGPS—acquired immunodeficiency syndrome	7.78e-05	0.00847	CbGpPWpGaD
Metformin—NDUFV3—Metabolism—AGPS—acquired immunodeficiency syndrome	6.94e-05	0.00755	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—TAT—acquired immunodeficiency syndrome	6.94e-05	0.00755	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—TAT—acquired immunodeficiency syndrome	6.94e-05	0.00755	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—TAT—acquired immunodeficiency syndrome	6.94e-05	0.00755	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—TAT—acquired immunodeficiency syndrome	6.52e-05	0.0071	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—AGPS—acquired immunodeficiency syndrome	5.9e-05	0.00642	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—AGPS—acquired immunodeficiency syndrome	5.9e-05	0.00642	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—AGPS—acquired immunodeficiency syndrome	5.9e-05	0.00642	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—AGPS—acquired immunodeficiency syndrome	5.55e-05	0.00603	CbGpPWpGaD
Metformin—ND1—Metabolism—TAT—acquired immunodeficiency syndrome	4.47e-05	0.00486	CbGpPWpGaD
Metformin—SLC29A4—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	4.01e-05	0.00436	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	3.87e-05	0.00421	CbGpPWpGaD
Metformin—ND1—Metabolism—AGPS—acquired immunodeficiency syndrome	3.8e-05	0.00414	CbGpPWpGaD
Metformin—PRKAB1—IRS-mediated signalling—IL6—acquired immunodeficiency syndrome	3.52e-05	0.00383	CbGpPWpGaD
Metformin—PRKAB1—IRS-related events—IL6—acquired immunodeficiency syndrome	3.43e-05	0.00373	CbGpPWpGaD
Metformin—PRKAB1—IRS-related events triggered by IGF1R—IL6—acquired immunodeficiency syndrome	3.4e-05	0.0037	CbGpPWpGaD
Metformin—PRKAB1—IGF1R signaling cascade—IL6—acquired immunodeficiency syndrome	3.31e-05	0.0036	CbGpPWpGaD
Metformin—PRKAB1—Insulin receptor signalling cascade—IL6—acquired immunodeficiency syndrome	3.31e-05	0.0036	CbGpPWpGaD
Metformin—SLC47A1—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	2.92e-05	0.00318	CbGpPWpGaD
Metformin—PRKAB1—Signaling by Insulin receptor—IL6—acquired immunodeficiency syndrome	2.75e-05	0.00299	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	2.34e-05	0.00255	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	2.34e-05	0.00255	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	2.12e-05	0.00231	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—TAT—acquired immunodeficiency syndrome	2.08e-05	0.00227	CbGpPWpGaD
Metformin—NDUFB11—Metabolism—ALB—acquired immunodeficiency syndrome	1.88e-05	0.00204	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—AGPS—acquired immunodeficiency syndrome	1.77e-05	0.00193	CbGpPWpGaD
Metformin—NDUFA12—Metabolism—ALB—acquired immunodeficiency syndrome	1.72e-05	0.00187	CbGpPWpGaD
Metformin—NDUFA1—Metabolism—ALB—acquired immunodeficiency syndrome	1.72e-05	0.00187	CbGpPWpGaD
Metformin—NDUFA11—Metabolism—ALB—acquired immunodeficiency syndrome	1.72e-05	0.00187	CbGpPWpGaD
Metformin—NDUFB3—Metabolism—ALB—acquired immunodeficiency syndrome	1.72e-05	0.00187	CbGpPWpGaD
Metformin—ND4—Metabolism—ALB—acquired immunodeficiency syndrome	1.6e-05	0.00174	CbGpPWpGaD
Metformin—ND4L—Metabolism—ALB—acquired immunodeficiency syndrome	1.6e-05	0.00174	CbGpPWpGaD
Metformin—NDUFA4—Metabolism—ALB—acquired immunodeficiency syndrome	1.6e-05	0.00174	CbGpPWpGaD
Metformin—NDUFB7—Metabolism—ALB—acquired immunodeficiency syndrome	1.6e-05	0.00174	CbGpPWpGaD
Metformin—ND5—Metabolism—ALB—acquired immunodeficiency syndrome	1.6e-05	0.00174	CbGpPWpGaD
Metformin—NDUFA7—Metabolism—ALB—acquired immunodeficiency syndrome	1.6e-05	0.00174	CbGpPWpGaD
Metformin—NDUFA9—Metabolism—ALB—acquired immunodeficiency syndrome	1.6e-05	0.00174	CbGpPWpGaD
Metformin—NDUFA5—Metabolism—ALB—acquired immunodeficiency syndrome	1.6e-05	0.00174	CbGpPWpGaD
Metformin—NDUFB10—Metabolism—ALB—acquired immunodeficiency syndrome	1.6e-05	0.00174	CbGpPWpGaD
Metformin—ND6—Metabolism—ALB—acquired immunodeficiency syndrome	1.6e-05	0.00174	CbGpPWpGaD
Metformin—NDUFS8—Metabolism—ALB—acquired immunodeficiency syndrome	1.6e-05	0.00174	CbGpPWpGaD
Metformin—NDUFB8—Metabolism—ALB—acquired immunodeficiency syndrome	1.6e-05	0.00174	CbGpPWpGaD
Metformin—NDUFB4—Metabolism—ALB—acquired immunodeficiency syndrome	1.6e-05	0.00174	CbGpPWpGaD
Metformin—NDUFS4—Metabolism—ALB—acquired immunodeficiency syndrome	1.6e-05	0.00174	CbGpPWpGaD
Metformin—NDUFA10—Metabolism—ALB—acquired immunodeficiency syndrome	1.6e-05	0.00174	CbGpPWpGaD
Metformin—NDUFV1—Metabolism—ALB—acquired immunodeficiency syndrome	1.6e-05	0.00174	CbGpPWpGaD
Metformin—ND3—Metabolism—ALB—acquired immunodeficiency syndrome	1.6e-05	0.00174	CbGpPWpGaD
Metformin—NDUFB6—Metabolism—ALB—acquired immunodeficiency syndrome	1.6e-05	0.00174	CbGpPWpGaD
Metformin—NDUFB1—Metabolism—ALB—acquired immunodeficiency syndrome	1.6e-05	0.00174	CbGpPWpGaD
Metformin—NDUFA6—Metabolism—ALB—acquired immunodeficiency syndrome	1.6e-05	0.00174	CbGpPWpGaD
Metformin—NDUFA2—Metabolism—ALB—acquired immunodeficiency syndrome	1.6e-05	0.00174	CbGpPWpGaD
Metformin—NDUFS5—Metabolism—ALB—acquired immunodeficiency syndrome	1.6e-05	0.00174	CbGpPWpGaD
Metformin—NDUFAB1—Metabolism—ALB—acquired immunodeficiency syndrome	1.6e-05	0.00174	CbGpPWpGaD
Metformin—NDUFB5—Metabolism—ALB—acquired immunodeficiency syndrome	1.6e-05	0.00174	CbGpPWpGaD
Metformin—NDUFS1—Metabolism—ALB—acquired immunodeficiency syndrome	1.6e-05	0.00174	CbGpPWpGaD
Metformin—NDUFC1—Metabolism—ALB—acquired immunodeficiency syndrome	1.6e-05	0.00174	CbGpPWpGaD
Metformin—NDUFA8—Metabolism—ALB—acquired immunodeficiency syndrome	1.6e-05	0.00174	CbGpPWpGaD
Metformin—NDUFB9—Metabolism—ALB—acquired immunodeficiency syndrome	1.6e-05	0.00174	CbGpPWpGaD
Metformin—NDUFS6—Metabolism—ALB—acquired immunodeficiency syndrome	1.6e-05	0.00174	CbGpPWpGaD
Metformin—NDUFA3—Metabolism—ALB—acquired immunodeficiency syndrome	1.6e-05	0.00174	CbGpPWpGaD
Metformin—NDUFB2—Metabolism—ALB—acquired immunodeficiency syndrome	1.6e-05	0.00174	CbGpPWpGaD
Metformin—ND2—Metabolism—ALB—acquired immunodeficiency syndrome	1.6e-05	0.00174	CbGpPWpGaD
Metformin—NDUFV2—Metabolism—ALB—acquired immunodeficiency syndrome	1.6e-05	0.00174	CbGpPWpGaD
Metformin—NDUFA13—Metabolism—ALB—acquired immunodeficiency syndrome	1.6e-05	0.00174	CbGpPWpGaD
Metformin—SLC22A3—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	1.53e-05	0.00166	CbGpPWpGaD
Metformin—SLC47A1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.48e-05	0.00161	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.45e-05	0.00158	CbGpPWpGaD
Metformin—NDUFV3—Metabolism—ALB—acquired immunodeficiency syndrome	1.42e-05	0.00155	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.31e-05	0.00143	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—TAT—acquired immunodeficiency syndrome	1.31e-05	0.00142	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.23e-05	0.00134	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.23e-05	0.00134	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—TAT—acquired immunodeficiency syndrome	1.22e-05	0.00132	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—ALB—acquired immunodeficiency syndrome	1.21e-05	0.00132	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—ALB—acquired immunodeficiency syndrome	1.21e-05	0.00132	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—ALB—acquired immunodeficiency syndrome	1.21e-05	0.00132	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—ALB—acquired immunodeficiency syndrome	1.14e-05	0.00124	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—AGPS—acquired immunodeficiency syndrome	1.11e-05	0.00121	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—AGPS—acquired immunodeficiency syndrome	1.04e-05	0.00113	CbGpPWpGaD
Metformin—SLC22A2—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	9.57e-06	0.00104	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	9.37e-06	0.00102	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	9.23e-06	0.001	CbGpPWpGaD
Metformin—SLC22A1—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	8.92e-06	0.000971	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.44e-06	0.000919	CbGpPWpGaD
Metformin—ND1—Metabolism—ALB—acquired immunodeficiency syndrome	7.79e-06	0.000848	CbGpPWpGaD
Metformin—SLC22A3—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	7.75e-06	0.000844	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.88e-06	0.000531	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	4.86e-06	0.000529	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	4.53e-06	0.000493	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—ALB—acquired immunodeficiency syndrome	3.63e-06	0.000395	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.87e-06	0.000312	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ALB—acquired immunodeficiency syndrome	2.28e-06	0.000248	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ALB—acquired immunodeficiency syndrome	2.12e-06	0.000231	CbGpPWpGaD
